wegovy
novo nordisk a/s - semaglutide - obesity; overweight - antiobesity preparater, ekskl. diettprodukter - wegovy is indicated as an adjunct to a reduced-calorie diet and increased physical activity for weight management, including weight loss and weight maintenance, in adults with an initial body mass index (bmi) of- ≥30 kg/m² (obesity), or- ≥27 kg/m² to.
xultophy 100 e/ ml / 3.6 mg/ ml
2care4 aps - insulin degludek / liraglutid - injeksjonsvæske, oppløsning i ferdigfylt penn - 100 e/ ml / 3.6 mg/ ml
novorapid flexpen 100 e/ ml
orifarm as - insulin aspart - injeksjonsvæske, oppløsning i ferdigfylt penn - 100 e/ ml
zelys 1.25 mg
ceva santé animale - pimobendan - tyggetablett - 1.25 mg
zelys 5 mg
ceva santé animale - pimobendan - tyggetablett - 5 mg
jaydess 13.5 mg
bayer ab - solna - levonorgestrel - intrauterint innlegg - 13.5 mg
kyleena 19.5 mg
bayer ab - solna - levonorgestrel - intrauterint innlegg - 19.5 mg
mirena 20 mikrog/24 timer
bayer ab - solna - levonorgestrel - intrauterint innlegg - 20 mikrog/24 timer
mirena 20 mikrog/24 timer
farmagon - levonorgestrel - intrauterint innlegg - 20 mikrog/24 timer
mirena 20 mikrog/24 timer
farmagon - levonorgestrel - intrauterint innlegg - 20 mikrog/24 timer